22071 Fraserwood Way
Richmond, BC V6W 1J5
Full Time Employees:
|Mr. Tim Moore||CEO & Director||134.8k||N/A||1959|
|Mr. Gordon Clissold FCGA, FCPA||Chief Financial Officer||N/A||N/A||N/A|
|Ms. Jenna Pozar||Chief Operations Officer||N/A||N/A||N/A|
|Dr. Ivan Casselman||Chief Psychedelic Officer||N/A||N/A||N/A|
|Mr. Alexzander Samuelsson||Chief Research Officer||N/A||N/A||N/A|
|Mr. Paul More||Controller||N/A||N/A||N/A|
HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp. mushrooms; and the genera directive compounds, such as psilocybin, psilocin, and baeocystin, as well as the development of natural health care products from non-regulated compounds. The company was incorporated in 2020 and is headquartered in Richmond, Canada.
HAVN Life Sciences Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.